Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses

被引:89
作者
Stassen, HH [1 ]
Angst, J [1 ]
DeliniStula, A [1 ]
机构
[1] F HOFFMANN LA ROCHE & CO LTD,CNS MED RES,CH-4002 BASEL,SWITZERLAND
关键词
D O I
10.1055/s-2007-979551
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The onset of action of antidepressant drugs was investigated on the basis of two independent, multicenter, double-blind studies, comparing amitriptyline (N = 120), oxaprotiline (N = 120), imipramine (N = 506) and moclobemide (N = 580) with placebo (N = 189 /+ 191). Highly significant differences between the active drugs and placebo were found with respect to the total number of improvers and the total number of responders. In addition, significant differences between treatment modalities showed up in both the percentage rate and the time distribution of premature withdrawals. However, among improvers, the distribution of time spans to onset of improvement was found to be independent of treatment modality, indicated by virtual ly identical cumulative percentages of improvers over the whole observation period. This picture of treatment-independent improvement rates was essentially the same for the HAMD, HAMA and ZUNG assessments, except for a significant time lag between observerratings and selfratings. Specifically, our analyses revealed no evidence for a delayed onset of action of various antidepressants with large biochemical and pharmacological differences when compared to placebo. The early onset of improvement was highly predictive of later outcome: on average, 70% of patients showing improvement within the first 14 days became responders. Differences between active treatments and placebo emerged within the first five days and reached a point of maximum distinction around day 14. After this time point, differences between treatment modalities remained constant until the end of the observation period. Not more than 20 - 25% of patients were, on average, ''true'' drug responders, thus suggesting that the therapeutic qualities of antidepressants do not lie in the suppression of symptoms, but rather relate to their ability to elicit and maintain certain conditions which enable recovery in a subgroup of patients who would otherwise remain nonresponders.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 30 条
[1]   IS A CUTOFF SCORE A SUITABLE MEASURE OF TREATMENT OUTCOME IN SHORT-TERM TRIALS IN DEPRESSION - A METHODOLOGICAL METAANALYSIS [J].
ANGST, J ;
DELINISTULA, A ;
STABL, M ;
STASSEN, HH .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1993, 8 (05) :311-317
[2]  
Angst J, 1994, SPEZIELLE ASPEKTE AN, P147
[3]  
ANGST J, 1978, S MED HOECHST, V13, P468
[4]  
BLIER P, 1990, J CLIN PSYCHIAT, V51, P14
[5]  
DELINISTULA A, 1982, ADV BIOCHEM PSYCHOPH, V31, P265
[6]  
DONLON PT, 1981, J CLIN PSYCHIAT, V42, P11
[7]   CUMULATIVE MEAN CHANGE PROCEDURE - APPLICATION TO A COMPARATIVE TRIAL OF VENLAFAXINE, IMIPRAMINE, AND PLACEBO IN THE TREATMENT OF MAJOR DEPRESSION [J].
ENTSUAH, AR ;
BRADLEY, MM ;
LITTMAN, GS .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (04) :695-706
[8]  
GACHOUD JP, 1992, PSYCHOPHARMACOLOGY, V106, P96
[9]   ANALYSIS OF TIME TO STABILIZATION IN THE TREATMENT OF DEPRESSION - BIOLOGICAL AND CLINICAL CORRELATES [J].
GREENHOUSE, JB ;
KUPFER, DJ ;
FRANK, E ;
JARRETT, DB ;
REJMAN, KA .
JOURNAL OF AFFECTIVE DISORDERS, 1987, 13 (03) :259-266
[10]   AN INTRODUCTION TO SURVIVAL ANALYSIS - STATISTICAL-METHODS FOR ANALYSIS OF CLINICAL-TRIAL DATA [J].
GREENHOUSE, JB ;
STANGL, D ;
BROMBERG, J .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1989, 57 (04) :536-544